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The murine blast cell colony assay offers a unique method to study the mecha-
nisms controllingthe primitive hemopoietic progenitors(1). Theprogenitorsforthe
blast cell colonies present in mice treated with 5-fluorouracil (5-FU)' probably rep-
resent the most primitive stem cells difinable in culture (2). Current studies have
shown that IL-3 and granulocyte-macrophage CSF (GM-CSF) have direct action
on the development ofmultipotential hemopoietic progenitors as well as committed
progenitors (3, 4). Hemopoietin-1 (5, 6), which is probably identical to IL-1a (7),
and a growth factor(s) produced by a murine adherent marrow cell line (8) have
beenreported asanew class ofhemopoietic growth factorswithsynergistic activities
on multilineage colony formation. These factors have been demonstrated to possess
no capacity to stimulate hemopoietic colony formation by themselves but enhance
the effects of other hemopoietic factors.
Human B cell stimulatory factor 2/interleukin 6(BSF2/IL-6)(9), identical to IFN-
a-2 (10, 11), a 26-kD protein (12) hybridoma/plasmacytoma growth factor (13), has
been demonstrated to act on the proliferation and differentiation of B cells at the
late stage and induce the production ofIg. Recently, Ikebuchi et al. (14) presented
evidence that human BSF2 interacts with IL-3 on murine multipotential progen-
itors, and at least part of the effect results from a decrease in the Go period ofthe
individual stem cells.
In this study, we examined theeffectsofhuman BSF2 on thedevelopmentofmu-
rine hemopoieticprogenitorsusing serum-free and serum-containing culture systems.
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Materials and Methods
Cell Preparation.
￿
10-15-wk-old female BDF, mice were obtained from the Shizuoka Ex-
perimental Animal Center (Shizuoka, Japan). Spleen cells were prepared by teasing the spleen
in 3 ml of a medium (Flow Laboratories, Inc., Rockville, MD) in a 35-mm Lux suspension
culture dish (5221R; Miles Laboratories, Inc., Naperville, IL), by repeated pipetting, and
by passage through a 100-gauge wire mesh. Bone marrow cells were flushed from femurs
into a medium by using a 26-gauge needle and single cell suspensions prepared in a medium .
5-FU (F. Hoffman-La Roche Co., Ltd., Basel, Switzerland) was administered through the
tail vein of the mice at a dosage of 150 mg/kg body weight (15). Spleen cells were harvested
4 d after the 5-FU injection, and bone marrow cells were harvested 2 d after the treatment.
Colony-stimulating Factors and Antiserum.
￿
Human recombinant BSF2 was prepared by ex-
pressing a cDNA for BSF2 (9) in Escherichia coli, followed by further purification (16). Specific
activity was determined as 3 .6 x 109 U/g by using the BSF2-responsive human B lympho-
blastoid cell line, SKW6-CL4. Murine IL-3 was a generous gift by Dr. Ken-ichi Arai, DNAX,
Research Institute of Molecular and Cellular Biology, Palo Alto, CA. Human recombinant
erythropoietin (Ep) was kindly provided by Kirin-Amgen (Tokyo, Japan). Human IL-1a and
anti-human IL-1a rabbit serum were generously provided by Dr. Yoshikatsu Hirai, Otsuka
Pharmaceutical Co., Ltd., Tokushima, Japan. Specific activity of IL-la was determined as
2 x 10' U/mg protein by using the lymphocyte activation assay and a 1:123,000 dilution of
anti-IL-la serum (OCT 303) neutralized the activity of 10 U (0.5 ng) of IL-1a (17). Serum-
free pokeweed mitogen-stimulated murine spleen cell-conditioned medium (PWM-SCM)
was prepared as described previously (1).
Clonal Cell Cultures.
￿
Serum-free clonal culture was carried out in 35-mm Lux suspension
culture plates by using a modification (18) of the technique described by Iscove et al. (19).
Unless otherwise specified, the culture consisted of 4-6 x 105/ml spleen cells from normal
mice, 1.0-1.5 x 106/ml spleen cells, or 4 x 104/ml bone marrow cells from 5-FU-treated mice,
a medium (Flow Laboratories), 0.9% methylcellulose (Shinetsu Chemical Co., Tokyo, Japan),
1% crystallized deionized BSA (Calbiochem-Behring Corp., La Jolla, CA), 10-4 M mercap-
toethanol (Eastman Organic Chemicals, Rochester, NY), 300 Pg/ml of fully iron-saturated
human transferrin (N98% pure, Sigma Chemical Co., St. Louis, MO), 160 Pg/ml of soy-
bean lecithin (Sigma Chemical Co.), 96 wg/ml of cholesterol (Nakarai Chemicals Ltd., Kyoto,
Japan), and 80 ng/ml of BSF2, 400 U/ml ofIL-3 and/or 2 U/ml of Ep. The standard cultures
contained 30% FCS (HyClone Laboratories, Inc., Logan, UT) instead of a combination
of transferrin, lecithin, and cholesterol. Plates were incubated at 37°C in a humidified at-
mosphere flushed with 5% C02 in air.
Determination of Colony Types and Sizes.
￿
Colony types were determined by daily observation
in situ on an inverted microscope. We used "mapping studies" to determine the full potential
of colonies supported by BSF and/or IL-3 (2, 18). When a new colony appeared, its location
on the plate was recorded and subsequent growth and differentiation followed every day. Colony
type was classified according to the criteria described previously (1, 20, 21). Abbreviations
for the colony types are GM, granulocyte-macrophage; B, erythroid bursts; M, megakaryo-
cyte; EM, erythrocyte-megakaryocyte; GEM, granulocyte-erythrocyte-macrophage; GMM,
granulocyte-macrophage-megakaryocyte; GEMM, granulocyte-erythrocyte-macrophage-
megakaryocyte; MAST, mast cell; and BLAST, blast cell.
The size of small colonies (consisting of <500 cells) was determined by counting individual
cells in situ with x 150 on an inverted microscope. Colonies consisting of >500 cells were in-
dividually lifted by an Eppendorfmicropipet, and made into single cell suspensions. Colony
size was estimated by using a counting chamber. In some experiments, colony types were
determined by differential counting ofthe Cytospin preparations stained with May-Grunward-
Giemsa.
Replating Experiments.
￿
To determine the potential of the blast cell colonies, we carried out
replating experiments of individual blast cell colonies seen in cultures of spleen cells from
normal or 5-FU-treated mice in the presence of 80 ng/ml of BSF2. Individual blast cell colo-
nies were picked up with an Eppendorf micropipet on an inverted microscope and plated
in a secondary culture containing 2 U/ml of Ep and 10% PWM-SCM. Cultures of replated
cells were incubated, and secondary colonies were scored in the same manner as primary
cultures.Results
Dose Response ofColony Formation to BSF-2.
￿
To determine the optimal concentra-
tion ofBSF2, we examined colony formation by 2 x 106 spleen cells of5-FU-treated
mice at BSF2 concentrations from 0.6-160 ng/ml in the presence ofFCS. The max-
imal number oftotal colonies was seen with 40-160 ng/ml ofBSF2 as shown in Fig.
1. Thus, BSF2 at 80 ng/ml was used in subsequent studies.
Colony Formation Supported by BSF-2 or IL-3 in Serum-containing Culture.
￿
We com-
pared the types and numbers ofcoloniesformed in serum-containingcultureby spleen
cells ofnormal and 5-FU-treated mice supported by 80 ng/ml ofBSF2 with those
supported by 400 U/ml of IL-3, which was shown to be the optimal concentration
forthe developmentofvarious typesofcolonies(3, 18, 22). Theresultsarepresented
in Table I. The number of total colonies supported by BSF2 was approximately
one-fifth and one-half ofthose supported byIL-3 derived from spleen cells ofnormal
mice and 5-FU-treated mice, respectively. Manydifferent typesofcoloniesincluding
GM, M, GMM, MAST, andblast cell colonies were formed inthe presence ofIL-3.
Serial observationsofculture dishes containing spleen cellsofnormal or5-FU-treated
mice demonstrated that BSF2 supported sequential appearance ofblast cell colo-
nies after day 7, similar to those supported by IL-3 or GM-CSF (4, 22). Most of
theblastcell colonies showed terminal differentiation into GM, M, and GMMcolo-
nies until 16 d ofincubation. However, some of them retained the morphological
characteristics ofblastcell colonies on day 16. BSF2did not support mast cellcolony
formation. Cytological analysis showed thatthe 11 randomly chosen mature day 16
colonies supported by BSF2 derived from spleen cells of normal mice consisted of
one macrophage colony, two megakaryocyte colonies, four neutrophil-macrophage
colonies, and four neutrophil-macrophage-megakaryocyte colonies.
ReplatingExperiment ofBlastCellColoniesSupportedbyBSF-2.
￿
Sincemost ofthecolonies
supported by BSF2 revealed an early nature, we examined the potentiality ofblast
cell colonies grown in the presence of BSF2 derived from spleen cells of normal
mice and 5-FU-treated mice using replating experiments. Spleen cells (4 x 105) of
normal mice were plated in a culture dish containing 80 ng/ml ofBSF2 and FCS.
17 colonies were seen in a culture dish until day 16. Seven ofthem were identified
as small GM colonies onday 7. We individually lifted and replated 8 out of 10 blast
cell colonies seen from day 7-15 into secondary culture dishes containing 2 U/ml
ofEp and 10°Jo PWM-SCM. The results are presented in Table II. Blast cell colo-
nies revealed variable but high replating efficiencies. Fiveout ofeight blast cellcolo-
nies yielded secondary multilineage colonies including GEM, GMM, and GEMM
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FIGURE 1.
￿
Dose response of colony formation by spleen
cells of 5-FU-treated mice to BSF2. The number of colo-
nies derived from a total of 2 x 106 cells in two dishes was
counted.882
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TABLE I
Colony Formation by Spleen Cells ofNormal or 5-FU-treated Mice in
Serum-containing Culture
Number of colonies was derived from a total of 1 .6 x 106 spleen cells of nor-
mal mice and from a total of 4 x 106 spleen cells of 5-FU-treated mice in four
dishes. BSF-2, 80 ng/ml ; IL-3, 400 U/ml.
colonies. These results were comparable with those obtained by the replating ex-
periment of blast cell colonies derived from spleen cells of 5-FU-treated mice in the
presence of 80 ng/ml of BSF2. These results suggested that BSF2 supported the
proliferation of multipotential progenitors preferentially in the presence of serum.
Colony FormationSupportedbyBSF-2orII,-3 inSerum,freeCulture.
￿
SinceFCS is poten-
tially an endogenous source of various types of colony stimulating factors, we car-
ried out studies using the serum-free culture technique (18). The number of total
colonies formed by spleen cells of 5-FU-treated mice grown in the presence of 10%
PWM-SCM in serum-free culture conditions was -80% of that formed in serum-
containing culture conditions (data not shown). Table III shows a comparison of
TABLE II
Replating Experiment ofBlast Cell Colonies Supported by BSF-2 Derivedfrom Spleen Cells
of Normal Mice and 5-FU-treated Mice
Spleen
cells
from:
Colony
number
Day of
harvest
Colony
size GM M
Secondary
GEM
colonies
GMM GEMM Total
Total
repating
efficiency
Normal %
mice 1 7 24 15 0 0 0 0 15 63
2 9 76 38 1 1 0 12 52 68
3 9 261 89 0 0 0 0 89 34
4 9 294 173 4 2 0 1 180 61
5 12 25 13 0 0 1 1 15 60
6 12 30 22 0 0 0 0 22 73
7 12 104 48 2 3 0 2 55 53
8 15 53 31 0 5 0 1 37 70
5-FU-treated
mice 1 15 246 102 1 0 13 14 130 53
2 15 257 139 0 0 0 0 139 54
3 16 167 101 0 3 0 2 106 63
4 16 176 90 0 0 0 0 90 51
5 16 207 145 0 0 0 1 146 71
6 16 255 139 0 0 0 0 139 55
7 17 95 66 0 0 0 0 66 69
8 17 137 85 0 0 0 1 86 63
Colony type BSF-2
Normal mice
IL-3 None BSF-2
5-FU-treated
IL-3
mice
None
GM 13 42 0 5 12 0
M 4 23 0 6 6 0
GMM 6 19 0 7 30 0
MAST 0 79 0 0 9 0
BLAST 8 1 0 9 3 0
Total 31 164 0 27 60 0KOIKE ET AL.
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TABLE III
Colony Formation by Spleen Cells of Normal Mice or
5-FU-treated Mice in Serumfree Culture
Number of colonies was derived from a total of 2.4 x 106 spleen cells of normal mice and
from a total of 4 x 106 spleen cells of 5-FU-treated mice in four dishes. BSF-2, 80 ng/ml;
IL-3, 400 U/ml.
colony formation supported byBSF2 and IL-3 in serum-free culture. IL-3 supported
the development ofmany different types ofcolonies by spleen cells ofboth normal
mice and 5-FU-treated mice. In contrast, nocolony growth was seen in the presence
of BSF2. These results suggest that BSF2 does not support colony formation by
itself and requires factor(s) present in the serum for colony formation.
Effect ofCombination ofBSF-2 andIL-3 in Serumfree Culture.
￿
Since IL-3 is one of
themost important factor(s)ontheproliferation and differentiation ofthe hemopoietic
progenitors (23, 24), it is possible that IL-3 is a candidate cooperating with BSF2
in the serum. We examined the effects ofBSF2 on the development ofvarious types
ofprogenitors supported by an optimal concentration ofIL-3. First, spleen cells of
normal mice were plated in culture dishes containing 2 U/ml of Ep, 400 U/ml of
IL-3, and/or 80 ng/ml of BSF2. As shown in Table IV, BSF2 did not increase the
number oftotal colonies or that oferythroid bursts supported by Ep. These results
suggested that BSF2 does not have a burst-promoting activity. BSF2 did not aug-
mentthe single lineagecolony growth (B, M, mast cell colony) oroligolineagecolony
growth (GM, EM colony) supported by 400 U/ml of IL-3 and Ep, which suggests
that BSF2 does not influence the development of maturer progenitors. The sum
ofthe numbers ofGEM, GMM, GEMM, andblast cellcolonies produced byspleen
cellscultured withEp, IL-3, and BSF2wassimilar tothat producedby culture with
Ep andIL-3. However, the majority ofmultipotential progenitorssupported byBSF2,
IL-3, and Ep developed into GEMM colonies on day 16. On the other hand, in
IL-3- and Ep-containingculture, halfofthemremained in thedevelopmental stages
ofGMM and blast cell colonies on day 16 and mostly differentiated into GEMM
colonies after day 16.
To study the preciseeffect ofBSF2 on the development ofmultipotential progen-
Spleen
Cells
from: Colony type
Serum-free
BSF-2 IL-3
culture
None
Serum-containing culture
BSF-2
Normal
mice GM 0 49 0 78
M 0 37 0 6
GMM 0 29 0 18
MAST 0 13 0 0
BLAST 0 8 0 6
Total 0 136 0 108
5-FU-treated
mice GM 0 10 0 18
M 0 3 0 10
GMM 0 12 0 10
MAST 0 4 0 0
BLAST 0 29 0 6
Total 0 58 0 44884
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TABLE IV
Effect ofBSF-2 on Colony Formation by Spleen CellsofNormalMice Supported
by 400 U/ml of IL-3 and/or 2 U/ml of Ep in Serumfree Culture
Number of colonies was derived from a total of 1 .6 x 106 spleen cells of nor-
mal mice in four dishes. BSF-2, 80 ng/ml; IL-3, 400 U/ml; Ep, 2 U/ml.
itors, we used spleen cells of 5-FU-treated mice in which primitive cells were en-
riched . The results are presented in Table V. The addition of BSF2 to the culture
containing 400 U/ml of IL-3 resulted in a significant increase in the number of total
colonies, including many GMM colonies. BSF2 augmented the IL-3-dependent colony
growth by bone narrow cells of5-FU-treated mice as well. The combination of BSF
2 and 400 U/ml of IL-3 yielded 87 colonies (26 GM, 21 M, 33 GMM, 2 MAST,
5 BLAST), and IL-3 alone yielded 33 colonies (18 GM, 8 GMM, 4 MAST, 3 BLAST)
from 1.2 x 105 cells in three dishes. No colony growth was seen in culture with BSF
2 alone. These results suggested that BSF2 acted synergistically with IL-3 on the
development of multipotential progenitors, not on that of the maturer progenitors.
Since BSF-2 was prepared by expressing a cDNA for BSF2 inE. coli, it is possible
that the effects of BSF2 resulted from endotoxin present in BSF2 samples. There-
fore, we examined whether the action of BSF2 was abolished by polymyxin B. Addi-
tion of polymyxin B (10 pg/ml) did not remove synergism of BSF2 and IL-3 (data
not shown).
Effect ofBSF-2 on Colony Formation Supported by suboptimal Concentrations ofIL-3 in
Serumflee Culture.
￿
Next, we examined the mechanism of synergism between BSF2
TABLE V
Effect of BSF-2 on Colony Formation by Spleen Cells of 5-FU-treated Mice
Supported by 400 U/ml of IL-3 in Serumfree Culture
Number of colonies was derived from a total of 6 x 106 spleen cells of 5-FU-
treated mice in four dishes. BSF-2, 80 ng/ml; IL-3, 400 U/ml.
Colony type Ep
Ep
+ BSF-2
Ep
+ IL-3
Ep
+ IL-3
+ BSF-2 None
GM 0 0 27 34 0
B 19 24 71 63 0
M 0 0 17 19 0
EM 2 0 29 21 0
GEM 0 0 7 7 0
GMM 0 0 15 6 0
GEMM 0 0 19 35 0
MAST 0 0 23 27 0
BLAST 0 0 9 0 0
Total 21 24 217 212 0
Colony type BSF-2 IL-3 BSF-2 + IL-3 None
GM 0 2 28 0
M 0 1 5 0
GMM 0 11 61 0
MAST 0 2 1 0
BLAST 0 7 2 0
Total 0 23 97 0KOIKE ET AL.
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and IL-3. We plated spleen cells of 5-FU-treated mice in the presence of 80 ng/ml
ofBSF2 and/or 1 or 4 U/ml ofIL-3. The resultsarepresented in TableVI. As shown
in the previous sections, no colony growth was seen in culture with BSF2 alone.
Very low concentrations of IL-3 supported the growth of zero or two colonies. On
the other hand, a combination of BSF2 and IL-3 resulted in a significant increase
in the number of colonies. Similar results were obtained in the culture containing
bone marrow cells of 5-FU-treated mice. The combination of 80 ng/ml of BSF2
and 4 U/ml of IL-3 supported the formation of seven colonies (six M, one GMM)
from 1.2 x 105 cells in three dishes, while each factor alone failed to support the
colony growth. It is possible that new colonies are formed in the culture with IL-3
alone and not with the combination of BSF2 and IL-3 after day 16 of incubation,
since Ikebuchi et al . (14) reported that human BSF2 shortens the time course of
appearance of colonies. Therefore, cultures containing spleen cells of 5-FU-treated
mice were maintained until day 30, and sequential observations were carried out.
A significant number ofnew colonies was seen in thepresence ofBSF2 and IL-3 after
day 16 of incubation; whereas, few new colonies grew with IL-3 alone (Table VI).
We previously demonstrated that the multilineage colonies appeared smaller in
lower concentrations of IL-3 than in higher concentrations of IL-3 (22). Based on
these results, we examined whether BSF2 was capable of enlarging the GMM colo-
nies supported by 40 U/ml of IL-3 derived from spleen cells of 5-FU-treated mice.
When a colony appeared to have matured and did not change its morphology or
size for 3 d, it was lifted from the methylcellulose medium by use of an Eppendorf
micropipet for the determination of colony size and morphological examination.
The results in Fig. 2 show a significant difference in the size of GMM colonies be-
tween the BSF2 and IL-3 group and the IL-3 group (p < 0.001) according to Stu-
dent's ttest on logarithms ofthe cell numbers of individual colonies, although BSF2
alone failed to support the colony growth. By contrast, there was no difference in
the size of the mast cell colonies between the two groups. These results suggested
that BSF2 enhanced the sensitivity of multipotential hemopoietic progenitors to
a low concentration of IL-3 .
Effect ofAnti-IL-la Serum on Colony Formation Supported by BSF-2 and IL-3.
￿
Since
Hemopoietin-1, probably identical to IL-1a (7), has been demonstrated to possess
TABLE VI
Effect of BSF-2 on Colony Formation Supported by 1 U/ml
or 4 U/ml of IL-3 in Serumfee Culture
Numbers ofcolonies derived from a total of 3 x 106 (Exp. 1) and 3.6 x 106 (Exp. 2) spleen
cells of 5-FU-treated mice in three dishes were counted until day 16 and numbers of colonies
in parentheses until day 30.
Colony type
Exp. 1
GM M GMM MAST BLAST Total
BSF-2(80 ng/ml) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0)
IL-3(1 U/ml) 0(1) 0(0) 0(0) 0(0) 0(0) 0(1)
IL-3(1 U/ml)+BSF-2(80 ng/ml) 1(1) 3(3) 3(4) 0(0) 1(1) 8(9)
Exp. 2
BSF-2(80 ng/ml) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0)
IL-3(4 U/ml) 0(0) 0(0) 0(0) 2(2) 0(0) 2(2)
IL-3(4 U/ml) + BSF-2(80 ng/ml) 3(6) 6(7) 12(22) 0(0) 1(0) 22(35)synergism with IL-3 (6), we examined whetherthe antiserum againsthuman IL-la
absorbed the synergistic effect ofBSF2 using serum-free culture system . We there-
fore added the anti-IL-1a serum to the culture dishes containing spleen cells of
5-FU-treated mice with 40 U/ml of IL-3 and 80 ng/ml of BSF2 or 2 ng/ml of IL-
1a . The results are presented in Fig. 3 . IL-la did not support colony formation by
itselfbut increased the number of total colonies grown in the presence of IL-3 . The
effect of 2 ng/ml of IL-la on the IL-3-dependent colony growth, comparable with
that of 20 ng/ml of IL-1a (data not shown), was less effective than that of BSF2
as reported by Ikebuchi et al . (14) . A 1:2,000 dilution of anti-IL-la serum reduced
the colony growth supported by IL-3 and IL-la to the level seen in culture with
IL-3 alone . On the other hand, the synergistic action between BSF2 and IL-3 was
not precipitated by the addition of antiserum.
Discussion
As previously indicated, IL-3 has beenshownto support proliferation anddifferen-
tiationofmultipotential progenitors as well as committedprogenitors to single lineages
(3) . Murine GM-CSF also has been demonstrated to possess direct effects on not
only GM progenitors but also multipotential progenitors, and the primitive cells
responding to GM-CSF are subpopulations ofmultipotential progenitors supported
FIGURE 3.
￿
Effect ofanti-IL-la
serum on colony formation sup-
ported by IL-3 andBSF2 orIL-
la . The number of colonies de-
rived from a total of 2.4 x 10 6
spleen cells of 5-FU-treated
mice was counted . IL-3, 40
U/ml ; BSF2, 80 ng/ml; IL-1a,
2 ng/ml ; Anti-IL-la serum,
1:2,000 .
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by IL-3 (4). On the other hand, hemopoietin-1 produced no hemopoietic colonies
by itself in the presence of FBS but acted synergistically with CSF1 in the genera-
tion of mononuclear phagocytic precursor cells (5) and with IL-3 on development
of multipotential hemopoietic cells (6). Quesenberry et al. (8) reported a growth
factor(s) in the medium conditioned by murine marrow-adherent cell line, TC-1,
which has shown multilineage synergistic activities with IL-3, GM-CSF, and CSF1
on bone marrow cells of normal and 5-FU-treated mice using a serum-containing
culture condition. They showed that this factor differs from hemopoietin-1, and the
major synergistic effect is on the size rather than on the number of colonies.
Thepresentstudydemonstrated that BSF2 supports multipotential blast cell colony
formationby spleen cells ofnormal and5-FU-treated mice in the presence ofserum.
These results were consistent with those reported by Ikebuchi et al. (14). However,
use of a serum-free culturemethod showed BSF2 alonehasno effect on colony growth,
suggesting that BSF2 fails to support colony formation by itself. Combination of
BSF2 and IL-3 in serum-free culture resulted in a significant increase of colony
formation by spleen cells and bone marrow cells of 5-FU-treated mice in compar-
ison with IL-3 alone; whereas, no effect by the addition of BSF2 was seen on the
number of single or oligolineage colonies by spleen cells of normal mice supported
by IL-3 and/or Ep. These results suggested that BSF2 and IL-3 act synergistically
on themultipotential progenitorsand not on that of thematurerprogenitors. Addi-
tion of BSF2 to culture with a lowconcentration of IL-3 with little effect on colony
formation resulted in a significant increase in the number of colonies. Synergistic
activities ofBSF2 and alow concentration ofIL-3 was also seen on thesize ofGMM
colonies. These results suggested that BSF2 enhances the susceptibility of multipoten-
tial progenitors to IL-3.
Hemopoietin-1, probably identical to IL-1a (7), was reported to act synergisti-
callywith IL-3 on development of multipotential hemopoietic cells(6). Our serum-
free culture study demonstrated that IL-1a also failed to support colony formation
by itselfbut enhanced the IL-3-dependent colony growth. However, synergistic ac-
tion of BSF2 was more effective than that of IL-1a and was not absorbed by the
addition of anti-IL-1a serum, suggesting that potentiating activity of BSF-2 was dis-
tinguishable from that of IL-la.
BSF2 supported multipotential blast cell colony formation and differentiation of
hemopoietic progenitors into neutrophil, macrophage, and megakaryocyte lineage
in the presence of serum. Serum-free culturedemonstrated that BSF2 requires factor(s)
present in serum for the manifestation of the activities. Combination of BSF2 and
IL-3 suggested that IL-3 is a candidate for synergistic action with BSF2. The level
of IL-3 in our FBS was <1 U/ml, according to the measurement using an IL-3-
dependent cell line, 32 D-cl line (data not shown). Addition of 1 U/ml of IL-3 to
serum-free culture containing BSF2 failed to restore the number of total colonies
to the level obtained by serum-containing culture with BSF2 alone, when spleen
cells of5-FU-treated mice were used (data not shown). Therefore, some factorsother
than IL-3 in FBS may also act with BSF2 synergistically. It may be related to the
results that BSF2 supported formation of small GM colonies until day 7 from spleen
cells of normal mice in a serum-containing culture condition.
BSF2 may possess several functions on hemopoietis. One of them is that BSF2
may advance the maturation ofmultipotential progenitors, because BSF2 hastened888
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the differentiation ofmultipotential progenitors in the culture with IL-3 and Ep when
target cells were spleen cells of normal mice. It appears to be related to the evidence
described by Ikebuchi et al. (14), that the combination of BSF2 and IL-3 hastened
the rate ofcolony appearance relative to that observed with either factor alone. However,
augmentation ofBSF2 on number and size ofcolonies supported by low IL-3 cannot
be interpreted by this mechanism. Another mechanism of synergism will be pro-
posed that BSF2 enhances the sensitivity of multipotential progenitors to IL-3 . If
the activities of IL-3 on hemopoietic progenitors are mediated by receptors, it may
suggest that BSF2 increases the numbers of receptors to IL-3 or upregulates the
affinity of receptors to IL-3 on the multipotential progenitors. Further studies are
required .
Summary
We investigated the effects of B cell stimulatory factor 2/interleukin 6 (BSF-2/IL-
6) on the development of murine hemopoietic progenitors using serum-containing
culture and serum-free culture. In serum-containing culture, BSF2 mainly supported
multipotential blast cell colonies from spleen cells of normal and 5-fluorouracil (5-
FU)-treated mice. In serum-free culture, no colony growth was seen in the presence
of BSF-2 . Addition of BSF-2 to the serum-free culture containing IL-3 resulted in
a significant increase in the number of colonies formed from multipotential progen-
itors in spleen cells and bone marrow cells of 5-FU-treated mice, whereas no effects
were seen on the number of single or oligolineage colonies formed by the spleen
cellsof normal mice. These results suggested that BSF2 and IL-3 act synergistically
on the multipotential progenitors but not on the maturer progenitors. When BSF2
was added to a culture containing low concentrations of IL-3 (1 U/ml, 4 U/ml), which
had little effect on colony formation, the number of total colonies formed by the
spleen cells and bone marrow cells of 5-FU-treated mice increased significantly. The
combination of BSF2 and 40 U/ml of IL-3 resulted in a significant enlargement
ofGMM colonies. Thus, BSF-2 appears to enhance the sensitivity of multipotential
hemopoietic progenitors to IL-3 .
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